Australia reviews asthma treatment protocols for children

02/20/2013 | BioSpectrum Asia

Australia is examining the problem of treating asthmatic children with fixed dose combinations without first prescribing a single-ingredient product (inhaled corticosteroid), a practice that goes against the prevailing asthma management guidelines. The country's main pediatric advisory group considers extensive FDC use to be a serious issue of quality medical care.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ